Reading Time: 4 minutesOver the past few years, a new class of drugs has gained enormous attention: GLP-1 receptor agonists, commonly known by brand names like Ozempic, Wegovy, and Mounjaro. Originally designed to help people manage Type 2 diabetes, these medications are now Read more…
VIDEO: This Week’s Best of our Network
Contact
Contact articles@usabusinessradio.net
for more information on articles on this site. bmuyco@
Recent Stories in DBJ
- Ozempic, Profits, and the $50 Billion Question: What Are We Really Solving?
- Federal Reserve Cuts Rates Again As Tariff Uncertainty Looms
- Sacred Pause: Entering December Grounded, Clear and Connected
- How Business Owners Should Manage Employee & Customer Retention During an Exit
- Access Denied: New California Laws Seek To Impose Safeguards on New and Emerging Technologies
Also in DBJ
- Living Paycheck to Paycheck
- Does the 3-Day Non-Work Week – Work? (Commonly Called the ‘4-Day Week’)
- Adam Shapiro is Back and He is Talking About Market Volatility and More
- The 5 Most Expensive Cities to Lease Commercial Real Estate
- Barbara Comstock to Do Ongoing Series on Tech and the Government on Price of Business
The author of the best selling finance book of all time celebrates its 20th anniversary in a series of interviews with Kevin Price on the Price of Business.
Kevin Price, Editor at Large of Daily Business Journal and host of the nationally syndicated Price of Business show writes frequently at Quora about issues ranging from politics to personality types. His favorite answers are also found at USA Business Radio.